A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Oct, 13 2025
Mar, 28 2025
Jun, 1 2026
Apr, 26 2025
Jul, 10 2025